🇺🇸 FDA
Patent

US 9206428

RNAi-mediated inhibition of histamine receptor H1-related conditions

granted A61PA61P11/02A61P11/06

Quick answer

US patent 9206428 (RNAi-mediated inhibition of histamine receptor H1-related conditions) held by Arrowhead Research Corporation expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arrowhead Research Corporation
Grant date
Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P11/02, A61P11/06, A61P17/00, A61P27/02